ghk cu with zinc GHK-CU - Research Peptide ghk cu пептид купить Ghk

To our partners at APD: Thank you for standing with us

The only Phase II human trial data that exist were never published in peer-reviewed form [8]

The 52-week ELEVATE UC 52 study showed 27% clinical remission in patients taking Velsipity versus 7.4% in those who were part of the placebo group at week 12, and 32.1% clinical remission compared with 6.7% at week 52

Until rigorous, randomized, placebo-controlled trials are conducted and published, the responsible position is to rely on proven, evidence-based approaches to recovery and healing, and to leave unapproved peptides where they belong for now: in the laboratory, not in your body.